legislation: 115-s-2885
Data license: Public Domain (U.S. Government data) · Data source: U.S. government sources, plus a few identifier registries; each is listed on the methodology page
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115-s-2885 | 115 | s | 2885 | Disclosing Pharmaceutical Company Windfall Profits Act of 2018 | Finance and Financial Sector | 2018-05-17 | 2018-05-17 | Read twice and referred to the Committee on Banking, Housing, and Urban Affairs. | Senate | Sen. Smith, Tina [D-MN] | MN | D | S001203 | 1 | Disclosing Pharmaceutical Company Windfall Profits Act of 2018 This bill amends the Securities Exchange Act of 1934 to require pharmaceutical companies to make certain public disclosures, including disclosures related to taxation, compensation, dividends, and spending on research and development. | 2023-01-11T13:42:30Z | https://www.congress.gov/bill/115th-congress/senate-bill/2885 |